Charles S Berkman - Net Worth and Insider Trading
Charles S Berkman Net Worth
The estimated net worth of Charles S Berkman is at least $4 Million dollars as of 2024-12-28. Charles S Berkman is the SVP, Gen. Counsel & Secretary of Ligand Pharmaceuticals Inc and owns about 28,906 shares of Ligand Pharmaceuticals Inc (LGND) stock worth over $3 Million. Charles S Berkman is also the Chief Legal Officer of OmniAb Inc and owns about 323,385 shares of OmniAb Inc (OABI) stock worth over $1 Million. Details can be seen in Charles S Berkman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Charles S Berkman has not made any transactions after 2024-12-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Charles S Berkman
Charles S Berkman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Charles S Berkman owns 3 companies in total, including Ligand Pharmaceuticals Inc (LGND) , Avista Public Acquisition Corp II (AHPA) , and OmniAb Inc (OABI) .
Click here to see the complete history of Charles S Berkman’s form 4 insider trades.
Insider Ownership Summary of Charles S Berkman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LGND | Ligand Pharmaceuticals Inc | 2021-02-04 | Asso. Gen. Counsel & Secretary |
| AHPA | Avista Public Acquisition Corp II | 2022-11-01 | See Remarks |
| OABI | OmniAb Inc | 2024-12-09 | See Remarks |
Charles S Berkman Latest Holdings Summary
Charles S Berkman currently owns a total of 2 stocks. Among these stocks, Charles S Berkman owns 28,906 shares of Ligand Pharmaceuticals Inc (LGND) as of February 4, 2021, with a value of $3 Million and a weighting of 73.11%. Charles S Berkman also owns 323,385 shares of OmniAb Inc (OABI) as of December 9, 2024, with a value of $1 Million and a weighting of 26.89%.
Latest Holdings of Charles S Berkman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LGND | Ligand Pharmaceuticals Inc | 2021-02-04 | 28,906 | 109.19 | 3,156,246 |
| OABI | OmniAb Inc | 2024-12-09 | 323,385 | 3.59 | 1,160,952 |
Holding Weightings of Charles S Berkman
Charles S Berkman Form 4 Trading Tracker
According to the SEC Form 4 filings, Charles S Berkman has made a total of 2 transactions in Ligand Pharmaceuticals Inc (LGND) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Ligand Pharmaceuticals Inc is the sale of 18,097 shares on February 4, 2021, which brought Charles S Berkman around $3 Million.
According to the SEC Form 4 filings, Charles S Berkman has made a total of 2 transactions in OmniAb Inc (OABI) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in OmniAb Inc is the sale of 8,022 shares on December 9, 2024, which brought Charles S Berkman around $33,131.
Insider Trading History of Charles S Berkman
- 1
Charles S Berkman Trading Performance
GuruFocus tracks the stock performance after each of Charles S Berkman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Charles S Berkman is 5.7%. GuruFocus also compares Charles S Berkman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Charles S Berkman within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Charles S Berkman's insider trading performs compared to the benchmark.
Performance of Charles S Berkman
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 10.2 | | | | | |
| Relative Return to S&P 500(%) | 9.45 | | | | | |
Charles S Berkman Ownership Network
Charles S Berkman Owned Company Details
What does Ligand Pharmaceuticals Inc do?
Who are the key executives at Ligand Pharmaceuticals Inc?
Charles S Berkman is the Asso. Gen. Counsel & Secretary of Ligand Pharmaceuticals Inc. Other key executives at Ligand Pharmaceuticals Inc include Chief Financial Officer Octavio Espinoza , CHIEF LEGAL OFFICER & Andrew Reardon , and VP & Finance and CFO Matthew E Korenberg .
Ligand Pharmaceuticals Inc (LGND) Insider Trades Summary
Over the past 18 months, Charles S Berkman made no insider transaction in Ligand Pharmaceuticals Inc (LGND). Other recent insider transactions involving Ligand Pharmaceuticals Inc (LGND) include a net sale of 70,748 shares made by Matthew E Korenberg , a net sale of 16,812 shares made by Octavio Espinoza , and a net sale of 13,500 shares made by Andrew Reardon .
In summary, during the past 3 months, insiders sold 4,510 shares of Ligand Pharmaceuticals Inc (LGND) in total and bought 0 shares, with a net sale of 4,510 shares. During the past 18 months, 106,293 shares of Ligand Pharmaceuticals Inc (LGND) were sold and 6,500 shares were bought by its insiders, resulting in a net sale of 99,793 shares.
Ligand Pharmaceuticals Inc (LGND)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ligand Pharmaceuticals Inc Insider Transactions
Charles S Berkman Mailing Address
Above is the net worth, insider trading, and ownership report for Charles S Berkman. You might contact Charles S Berkman via mailing address: 11085 North Torrey Pines Road, Suite 300, La Jolla Ca 92037.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
